Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Fuxi Huang"'
Autor:
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yunfei Yuan, Binkui Li
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Introduction Regorafenib remains the standard and widely used second‐line strategy for advanced hepatocellular carcinoma (HCC). There is still a lack of large‐scale multicenter real‐world evidence concerning the concurrent use of regor
Externí odkaz:
https://doaj.org/article/d7b100f5750b4f9486922d99dd9bd705
Autor:
Senmiao Huang, Dianhe Li, Yongye Huang, Guojie Lu, Ying Tian, Xuefeng Zhong, Yating Zheng, Mengli Huang, Fuxi Huang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Systemic chemotherapies are the primary treatment options for patients with unresectable and metastatic intrahepatic cholangiocarcinoma (ICC), but the effectiveness of current systemic therapies is limited. The development of targeted-therapy has cha
Externí odkaz:
https://doaj.org/article/3bec38c3f5c9423d9b264a84af028492
Publikováno v:
Journal of Natural Gas Geoscience, Vol 6, Iss 4, Pp 215-229 (2021)
A series of experimental techniques which contain casting thin slice observation, field emission scanning electron microscopy, high-pressure mercury injection, constant-velocity mercury injection, and NMR(nuclear magnetic resonance) were used to stud
Externí odkaz:
https://doaj.org/article/b65e40ed87464c26b16d9d0faf9d5407
Autor:
Xiaoshun Shi, Fuxi Huang, Xiaobing Le, Xiaoxiang Li, Kailing Huang, Baoxin Liu, Viola Yingjun Luo, Yanhui Liu, Zhuolin Wu, Allen Menglin Chen, Ying Liang, Jiexia Zhang
Publikováno v:
Translational Medicine Communications, Vol 2, Iss 1, Pp 1-8 (2017)
Abstract Background This study aimed to develop and assess a practical prognostic lncRNA signature for squamous cell carcinoma of the lung (LUSC). Methods RNA expression profile and clinical data from 388 LUSC patients were accessed and download from
Externí odkaz:
https://doaj.org/article/89ce9bdd2a9548d1aaa57281dd17a6e8
Publikováno v:
Journal of International Medical Research, Vol 46 (2018)
Pulmonary pleomorphic carcinoma (PPC) is rare, and the response of patients to conventional chemotherapy is very poor. Here we present a patient with anaplastic lymphoma kinase (ALK)-rearranged advanced PPC treated with crizotinib. Computed tomograph
Externí odkaz:
https://doaj.org/article/a5bac0152d8c4202b631187cddac091d
Autor:
Zhenwei Peng, Wenzhe Fan, Bowen Zhu, Guoying Wang, Junhui Sun, Chengjiang Xiao, Fuxi Huang, Rong Tang, Yu Cheng, Zhen Huang, Yuchuang Liang, Huishuang Fan, Liangliang Qiao, Fuliang Li, Wenquan Zhuang, Baogang Peng, Jiping Wang, Jiaping Li, Ming Kuang
Publikováno v:
Journal of Clinical Oncology. 41:117-127
PURPOSE Lenvatinib (LEN) is a first-line therapy for patients with advanced hepatocellular carcinoma (HCC); however, it has shown modest survival benefits. Therefore, we aimed to compare clinical outcomes of LEN combined with transarterial chemoembol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424349d82db206ad28d7ecab85a77155
https://doi.org/10.1200/jco.22.00392
https://doi.org/10.1200/jco.22.00392
Autor:
Fuxi Huang, Rongzhen Qiao, Shiguo Lin, Yuanqi She, Yang Gao, Shiwei Yi, Mingpeng Li, Zhonghong Chen
Publikováno v:
Journal of Petroleum Science and Engineering. 208:109634
Old strata and deep petroleum systems are becoming increasingly important. The Cambrian-Lower Ordovician petroleum reservoirs in the eastern Tazhong Uplift, central Tarim Basin, western China were studied comprehensively using various methods, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81efeab91f8264b71be5daf70d8201e4
https://doi.org/10.1016/j.petrol.2021.109634
https://doi.org/10.1016/j.petrol.2021.109634
Autor:
Xiaolong Cao, Jianjun Han, Fuxi Huang, Yan He, Guorong Zou, Liping Lin, Juanjuan Zhao, Jiazhu Hu
Publikováno v:
Journal of Cancer. 9:2140-2146
Objectives: The aim of this study is to investigate the predictive value of smoking history on treatment outcomes of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC patients without EGFR mutations and ALK rearrangements. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09148bd810da15d8d75a3756f4e1b92f
https://doi.org/10.7150/jca.24872
https://doi.org/10.7150/jca.24872
Autor:
Fuxi Huang, Ning Kong, Jiazhu Hu, Liping Lin, Xiaolong Cao, Juanjuan Zhao, Jianjun Han, Yan He
Publikováno v:
Oncotarget
// Liping Lin 1, 4, * , Juanjuan Zhao 2, * , Ning Kong 3, 4 , Yan He 1, 4 , Jiazhu Hu 1, 4 , Fuxi Huang 1, 4 , Jianjun Han 1, 4 and Xiaolong Cao 1, 4 1 Department of Oncology, Panyu Central Hospital, Guangzhou, 511400, China 2 School of Nursing, Sun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00dd12d9937bf58bfa827d16ae9d836
https://doi.org/10.18632/oncotarget.18283
https://doi.org/10.18632/oncotarget.18283
Autor:
Fuxi Huang, Qianqian Huang, Xiaoshun Shi, Jiexia Zhang, Zhuolin Wu, Xiaoxiang Li, Ying Liang, Allen M. Chen, Haiyun Mo, Qipeng Zhou
Publikováno v:
Open Journal of Genetics. :117-129
Background: Emerging evidence indicates that chemotherapy for lung cancer may alter EGFR mutation status. However, whether chemotherapy as a firstline treatment may increase or reduce the frequency of EGFR mutations in NSCLC remains uncertain. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42ba96b3b26900b208b450c2746a33b7
https://doi.org/10.4236/ojgen.2017.74010
https://doi.org/10.4236/ojgen.2017.74010